Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AGIOS PHARMACEUTICALS, INC. has filed 1,292 SEC EDGAR filings since 01 Jul 2008

SEC filing history

Showing 76-100 of 1,000 matching filings.

Per page
25
Current page
4
144 File 001-36014

144 filing

Filing date
30 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
30 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
30 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-87570

SCHEDULE 13G/A filing

Filing date
05 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-87570

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Nov 2025
Reporting date
12 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Nov 2025
Reporting date
11 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
12 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Nov 2025
Reporting date
30 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
30 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Oct 2025
Reporting date
27 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
27 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
10 Oct 2025
Reporting date
08 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
08 Oct 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2025
Reporting date
30 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
30 Sep 2025
Reporting date
26 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
30 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
26 Sep 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Sep 2025
Reporting date
05 Sep 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
29 Aug 2025
Reporting date
27 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G File 005-87570

SCHEDULE 13G filing

Filing date
28 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-36014

144 filing

Filing date
27 Aug 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
13 Aug 2025
Reporting date
11 Aug 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .